Cellectar Biosciences (United States)

Percutaneous Injection of Autologous Bone Marrow Concentrate Cells Significantly Reduces Lumbar Discogenic Pain Through 12 Months

Kenneth A. Pettine, Matthew B. Murphy, Richard K. Suzuki et al. · Stem Cells · 2014 · 205 citations

Percutaneous Injection, Intervertebral Disc, Pain Medicine +17

Overcoming Transcription Activator-like Effector (TALE) DNA Binding Domain Sensitivity to Cytosine Methylation

Julien Valton, Aurélie Dupuy, Fayza Daboussi et al. · Journal of Biological Chemistry · 2012 · 176 citations · Full text

Chromatin, Transcriptional Regulation, Natural Sciences +13

Autologous bone marrow concentrate intradiscal injection for the treatment of degenerative disc disease with three-year follow-up

Kenneth A. Pettine, Richard K. Suzuki, Theodore T. Sand et al. · International Orthopaedics · 2017 · 124 citations

Regenerative Medicine, Cell Therapy, Degenerative Spine +10

Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up

Kenneth A. Pettine, Richard K. Suzuki, Theodore T. Sand et al. · International Orthopaedics · 2015 · 112 citations

Regenerative Medicine, Bone Marrow Failure, Minimum Two +9

Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery

May P. Xiong, M. Laird Forrest, Giangthy N. Ton et al. · Biomaterials · 2007 · 111 citations

Cell-based Drug Delivery, Nanomedicine, High Transfection Efficiency +10